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Abstract
Background: Fecal incontinence (FI) is defined as the recurrent involuntary excretion of feces in inappropriate
places or at inappropriate times. It is a major and highly embarrassing health care problem which affects about 2
to 24% of the adult population. The prevalence increases with age in both men and women.
Physiotherapy interventions are often considered a first-line approach due to its safe and non-invasive nature
when dietary and pharmaceutical treatment fails or in addition to this treatment regime. Two physiotherapy
interventions, rectal balloon training (RBT) and pelvic floor muscle training (PFMT) are widely used in the
management of FI. However, their effectiveness remains uncertain since well-designed trials on the effectiveness
of RBT and PFMT versus PFMT alone in FI have never been published.
Methods/Design: A two-armed randomized controlled clinical trial will be conducted. One hundred and six
patients are randomized to receive either PFMT combined with RBT or PFMT alone. Physicians in the University
Hospital Maastricht include eligible participants. Inclusion criteria are (1) adults (aged ≥ 18 years), (2) with fecal
incontinence complaints due to different etiologies persisting for at least six months, (3) having a Vaizey
incontinence score of at least 12, (4) and failure of conservative treatment (including dietary adaptations and
pharmacological agents). Baseline measurements consist of the Vaizey incontinence score, medical history,
physical examination, medication use, anorectal manometry, rectal capacity measurement, anorectal sensation,
anal endosonography, defecography, symptom diary, Fecal Incontinence Quality of Life scale (FIQL) and the
PREFAB-score. Follow-up measurements are scheduled at three, six and 12 months after inclusion. Skilled and
registered physiotherapists experienced in women's health perform physiotherapy treatment. Twelve sessions
are administered during three months according to a standardized protocol.
Discussion: This section discusses the decision to publish a trial protocol, the actions taken to minimize bias and
confounding in the design, explains the choice for two treatment groups, discusses the secondary goals of this
study and indicates the impact of this trial on clinical practice.
Trial registration: The Netherlands Trial Register ISRCTN78640169.
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Background
Background of fecal incontinence
Fecal incontinence (FI) is a major health care problem,
that is particularly embarrassing and affects about 2 to
24% of the adult population, increasing to 47% in the
institutionalized elderly [1-7]. The actual prevalence is
likely to be higher due to the common underreporting of
FI as a result of patients' embarrassment to visit a physi-
cian or unawareness of possible treatment options [8]. FI
can be defined as the recurrent involuntary excretion of
feces in inappropriate places or at inappropriate times [7],
and covers a wide spectrum from involuntary but recog-
nized passage of gas, liquid, or solid stool (urge inconti-
nence) to unrecognized anal leakage of mucus, fluid, or
stool (passive incontinence) [9]. Fecal continence is based
on a combined interplay of sensory, motoric and reservoir
functions. Incontinence occurs if one or more of these
components fail and when compensatory mechanisms
fall short. Obstetric trauma is one of the major causes of
FI in women. Several colorectal, urological or gynaecolog-
ical interventions can cause FI as well. Specific neurologi-
cal diseases associated with FI include diabetes, multiple
sclerosis, Parkinson's disease, stroke, and spinal cord
injury.
FI is often thought to be associated with older people, as
a natural aspect of ageing. Recently, it has been estimated
that 6% of the persons aged 60 years and older suffer from
involuntary loss of feces and 3% from involuntary loss of
both feces and urine [8]. In addition, the prevalence of FI
will increase in the next fifteen years due to double ageing.
However, younger patients are often affected as well [1].
FI interacts with multiple aspects of daily life resulting in
a number of difficulties; having to stay at home near a toi-
let, having to avoid social contacts including relationships
or sexual contact, having feelings of depression and low
self-esteem [2]. Moreover, it is often difficult to explain
experiencing FI to others, like family or a partner. A lot of
these implications are due to the unpredictable character
of FI and the fear of odour or soiling [10].
Apart from a social burden to the patient, FI also has a sig-
nificant impact on the health care budget. Limited data
are available on healthcare costs for FI [9,11]. Recently,
total costs in the Netherlands were estimated at € 2169
per fecally incontinent patient a year [12].
Estimates of health care costs and prevalence numbers for
FI vary greatly and depend on the clinical setting and on
the definition of FI based on severity and frequency
[1,13,14].
Physiotherapy in fecal incontinence
Treatment of fecally incontinent patients consists of con-
servative as well as surgical interventions. Surgical inter-
ventions aim to anatomically and functionally correct the
rectum, anus, pelvic floor or anal sphincters. Conservative
interventions consist of dietary adaptations, medication,
absorbent materials, and physiotherapy. Physiotherapy
interventions are non-invasive and inexpensive, require
no sophisticated equipment and have hardly any adverse
effects. Besides, physiotherapy does not exclude any other
form of treatment [15]. Therefore, physiotherapy is often
attempted before surgical treatment.
Physiotherapy FI management includes pelvic floor mus-
cle training (PFMT), biofeedback (BF), rectal balloon
training (RBT) and electrical stimulation (ES). PFMT aims
to restore muscular strength, coordination and timing of
contractions. With BF the patient gets information about
the activity of the pelvic floor muscles by way of a visual
display. RBT, as a modality of BF, is used to decrease the
sensory threshold in case of passive FI and to increase the
sensory threshold in case of urge FI. In addition, RBT aims
to synchronize contraction of the external anal sphincter
with relaxation of the internal anal sphincter. ES is used to
increase awareness and isolated contraction of the anal
sphincters. Often, one or more physiotherapy interven-
tions are combined, depending on the underlying cause of
FI.
Over 60 uncontrolled trials exist on the use of biofeed-
back for the management of FI [16]. Some authors con-
clude that biofeedback is the treatment of choice for FI on
the basis of these observational studies [17]. An overall
cure and improvement rate of 72 percent has been
reported [18]. However, the results of a Cochrane review
on the effects of BF and/or PFMT for the treatment of FI in
adults were based on eleven randomized controlled but
heterogeneous trials and showed that some elements of
BF therapy and sphincter exercises might have a therapeu-
tic effect, but this is not certain [16]. Moreover, it was sug-
gested that RBT improved continence more than sham
training. This is in agreement with other authors who con-
sider lowering the threshold volume for discrimination of
rectal distension an important factor in the success of BF
[15,19-21].
In an attempt to assess the effect of the different BF com-
ponents (balloon/pressure BF, electromyographic BF) in
the management of FI, two complicated cross-over trials
have been performed [15,20]. Group comparison was
impossible to assess due to the small sample in one trial
(16) and the single case experiments in the other (21).
A second Cochrane review evaluated ES in adult patients
with FI [16,22]. Insufficient data was available to allow
reliable conclusions on the effect of ES in the manage-
ment of FI [22]. A recently published randomized control-
led trial examined whether anal ES, in the absence of anyBMC Public Health 2007, 7:355 http://www.biomedcentral.com/1471-2458/7/355
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adjunct exercises or advice, would improve symptoms
more when compared with "sham" ES. It is concluded
that 1 Hz (sham) was as effective as 35 Hz. Possibly, the
main effect is not sphincter contraction but sensitization
of the patient to the anal area, or simply the effect of inter-
vening per se (Hawthorne effect) [23].
Finally, the results of a recent large cohort study on ES and
PFMT with BF in patients with severe FI indicated that pel-
vic floor muscle rehabilitation leads to a modest improve-
ment in severity of FI, squeeze pressure and maximal
tolerated volume [24].
Although uncertainty exists on the exact extent of the
effectiveness of physiotherapy treatment in FI, results are
promising [18].
Relevance
Evaluating effectiveness of physiotherapy treatment has
been impeded by lack of enough quality studies, lack of
standardization, a large variety in outcome measures and
methodological flaws [25]. Ultimately, there is a need to
evaluate treatment options in FI, especially since FI con-
siderably reduces quality of life. Besides, FI has a signifi-
cant impact on the health care budgets, and the
prevalence of FI is increasing due to double ageing [26].
PFMT has been proven effective in the treatment of stress
urinary incontinence [27]. Since the anal sphincter and
puborectalis muscle form a part of the same pelvic floor as
the closing urethral system, expectations are raised for the
same positive results of pelvic floor muscle re-educative
techniques in FI. Next to PFMT, some authors consider
lowering the threshold volume for discrimination of rec-
tal distension as an important factor in the success of
physiotherapy [15,19-21]. No study has reported adverse
events from either PFMT or RBT, and it seems unlikely
that these treatments itself could cause symptoms to
worsen.
Apparently, PFMT and RBT seem to have a role in the
treatment of fecally incontinent patients. Since well-
designed trials on the effectiveness of RBT and PFMT ver-
sus PFMT alone in patients with FI have never been pub-
lished, a randomized controlled trial on this topic will be
carried out (Physiotherapy in Fecal Incontinence Trial –
PhysioFIT-study).
Methods/Design
Study design, research question and hypothesis
A two-armed randomized controlled clinical trial will be
conducted in patients diagnosed with FI (Figure 1), serv-
ing the following research question: what is the effective-
ness of rectal balloon training and pelvic floor muscle
training compared to pelvic floor muscle training alone in
patients with fecal incontinence?
It is hypothesized that patients receiving the combined
training will have a larger reduction on the primary out-
come measure.
Study population
The study population consists of patients living in the
Netherlands. Participants are eligible when they are diag-
nosed with FI after general diagnostics. The randomized
controlled trial is carried out at the University Hospital
Flowchart of the PhysioFIT-study Figure 1
Flowchart of the PhysioFIT-study. t = point in time; VS 
= Vaizey score; MH = medical history; M = medication use ; 
PE = physical examination; DI = diary; AM = anorectal man-
ometry; RC = rectal capacity measurement; AS = anorectal 
sensation; AE = anal endosonography; D = defecography; 
FIQL = fecal incontinence quality of life scale; PREFAB = 
modified PRAFAB-score; GPE = Global Perceived Effect-
score; PFMT = pelvic floor muscle training; RBT = rectal bal-
loon training; VS (-) = reduction on VS < 4 points; VS (+) = 
reduction on VS ≥ 4 points; GPE (+) = score 1–7 on GPE 
scale; GPE (-) = score 8 or 9 on GPE scale
First visit patient (t = 0 months)
Baseline measurements: VS, MH, M, PE
Meet inclusion criteria: DI
Ļ
Second visit patient (t = 3 months)
Baseline measurements: AM, RC, AS, AE, D
Scoring lists: FIQL, PREFAB
Informed consent
Ļ
Randomization
Ļ
Referral to physiotherapist (start follow-up)
Ļ
Trial arm 1: PFMT + RBT
Trial arm 2: PFMT
Ļ
Follow-up after 3 months
Measurements: M, AM, RC, AS, DI
Scoring lists: VS, FIQL, PREFAB, GPE
Ļ
Ļ
Ļ
Follow-up after 6 months
Measurements: M, AM, RC, AS, DI
  Scoring lists: VS, FIQL, PREFAB, GPE
Ļ
 Follow-up after 12 months
Measurements: M, AM, RC, AS, DI
Scoring lists: VS, FIQL, PREFAB, GPE
Ļ
    End study
Co-interventions
possible after 3
or 6 months
VS (+), GPE (+)
VS (+), GPE (-)
VS (-), GPE (+)
VS (-), GPE (-)BMC Public Health 2007, 7:355 http://www.biomedcentral.com/1471-2458/7/355
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Maastricht, where two colorectal surgeons (CB, WG)
include eligible participants. Inclusion criteria are (1)
adults (aged ≥ 18 years), (2) FI complaints due to different
etiologies persisting for at least six months, (3) Vaizey
incontinence score of at least 12 [28], (4) and failure of
conservative treatment (including dietary adaptations and
pharmacological agents). Inclusion criteria 2, 3 and 4
indicate that patients with moderate to severe FI com-
plaints are of interest. Patients diagnosed with an anorec-
tal tumor within the past two years, absent squeeze
pressure of the anal sphincter, chronic diarrhea (always
fluid stool three or more times a day), overflow inconti-
nence, proctitis, colitis ulcerosa, Crohn's disease, soiling
(defined as leakage of a minimal amount of feces out of
the anal canal), previous ileo-anal or colo-anal anastomo-
sis and/or rectal prolapse in situ are excluded. Participants
who received physiotherapy during the previous six
months or who are intellectually and/or linguistically
incapable to understand therapy are excluded as well.
Recruitment, informed consent and randomization
The medical ethics committee of the University Hospital
Maastricht/Maastricht University approved the PhysioFIT-
study. The physician points out during the first visit that
the patient is eligible to participate in the trial. The patient
is provided with patient information sheets and informa-
tion on the diagnostic tests. Participating patients sign
informed consent at the beginning of the second visit,
allowing eligible participants two months to decide to
participate.
An independent research assistant performed the blocked
randomization (size of four). A computer-generated rand-
omization list is prepared in advance. The independent
research assistant contacts the physiotherapist by tele-
phone to inform about the referral and the allocated treat-
ment.
Blinding
The research doctor, performing the general diagnostics,
and the researcher, dealing with the data-entry, are
blinded during baseline measurements but not during fol-
low-up measurements. However, the physician involved
in measuring the primary outcome measure is blinded
and blinded double data-entry is performed to assure cor-
rect data-entry. It is impossible to blind patients and par-
ticipating physiotherapists for treatment allocation.
However, physiotherapists are not involved in the diag-
nostic work-up and follow-up measurements. The out-
come assessors are blinded.
Baseline and follow-up measurements
Given the multiple etiologies in patients with FI, no test
should be expected to yield consistent results in all
patients with FI. Therefore, no standard protocol is avail-
able for the assessment and diagnosis of FI. The chosen
tests at baseline (except for the questionnaires) are recom-
mended by the American Gastroenterological Associa-
tion, being procedures of value (symptom diary, physical
examination, anal endosonography, anorectal manome-
try, rectal and anal sensory testing) and being procedures
of possible value (defecography) [29]. As these diagnostic
tests are part of the standard diagnostic assessment in the
University Hospital Maastricht, participation in the trial
will not burden the patient additionally. The following
baseline measurements are done during the first and sec-
ond patient visit:
▪ Vaizey incontinence score: this score reflects the severity
of FI and ranges from 0 (complete continence) to 24
(complete incontinence) (Table 1) [28]. The Vaizey score
is a widely used severity score and it is reported to be a
reproducible score, which correlates highly with physi-
cians' clinical impression [28]. Recently, it has also been
demonstrated that higher Vaizey scores are associated
with more reported problems in general health domains
[30] and that changes in Vaizey score reflect patients' sub-
jective perception of relief [31].
Table 1: Fecal incontinence score according to Vaizey et al. [28]
Incontinent Never Rarely Sometimes Weekly Daily
S o l i d  s t o o l 01234
L i q u i d  s t o o l01234
G a s 01234
A l t e r a t i o n  i n  l i f e s t y l e 01234
No Yes
Need to wear a pad or plug 02
Taking constipating medication 02
Lack of ability to infer defecation for 15 minutes 0 4
Minimum score = 0 = perfect continence; maximum score = 24 = totally incontinent Never: no episodes in the past 4 weeks; rarely: one episode in 
the past 4 weeks; sometimes: > 1 episode in the past 4 weeks, but < once a week; weekly: one or more episodes a week but < one a day; daily: one 
or more episodes a dayBMC Public Health 2007, 7:355 http://www.biomedcentral.com/1471-2458/7/355
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▪ Medical history: the medical history assesses gender, age,
duration of complaints, risk factors (surgical, obstetric,
neurological, metabolic) and medication use.
▪ Physical examination: digital rectal examination is used
to assess anal pressure at rest and pressure during contrac-
tion. Sphincter defects can be located and palpated, espe-
cially during contraction. In women, the presence of a
rectocele can be established.
▪ Anorectal manometry: anorectal manometry is per-
formed to measure anal sphincter pressures. The test is
performed in the left lateral position and flexed hips to 90
degrees. Anal manometry takes place according to the
water-perfused technique. The single use manometric
catheter (Medtronic Inc., Skovlunde, Denmark) is intro-
duced, which is connected to a computer-assisted poly-
graph (Polygraf™ ID, Medtronic Inc., Skovlunde,
Denmark) and stabilized in the anal sphincter complex.
After positioning the catheter in the maximal pressure
area, the basal sphincter pressure, maximum squeeze
pressure and rectal anal inhibitory reflex are measured.
▪ Rectal capacity measurement: the measurement is per-
formed by introducing a single use manometric catheter
(Medtronic Inc., Skovlunde, Denmark) in the rectum,
which is connected to a computer-assisted polygraph
(Polygraf™ ID, Medtronic Inc., Skovlunde, Denmark). The
catheter is inflated with air with slow increments. The vol-
umes are recorded at which first sensation is noticed (sen-
sory threshold), an urge to evacuate is produced (urge
sensation), and volume at which pain becomes intolera-
ble (maximum tolerated volume).
▪ Anorectal sensation: a St. Mark's glove pudendus elec-
trode is placed on the index finger and introduced into the
anal canal. An increasing electrical current (mAmp) is
gradually applied until the threshold of sensation is
reached. Anorectal sensation is measured at two places:
three o'clock and nine o'clock in the transversal plane.
▪ Anal endosonography: anal endosonography provides
an anatomical image of the anal sphincters and pelvic
floor. This technique gives an instant excellent image of
the condition of the sphincters and establishes the size of
a possible internal or external anal sphincter defect. Anal
endosonography is performed with an ultrasound scanner
with radial endoscopic probe and a 7.5-MHz transducer.
The probe is covered with a lubricant and a condom. After
application of a final lubricant the probe is introduced in
the anal canal with the patient in the left lateral or prone
position. The probe is slightly withdrawn, so all the differ-
ent levels of the anal sphincter complex can be visualized.
▪ Defecography: defecography is a dynamic radiological
study of attempted defecation and shows both the func-
tional aspects of defecation and defects in anorectal anat-
omy. Patients are instructed to drink contrast medium
diluted water before examination. The test starts with the
patient in left decubital position. Through an injection
pistol barium paste is manually injected in the rectum. In
female patients gel is also injected via a syringe in the
vagina. The perineum is located with a gel solution as
well. Subsequently, the entire x-ray table is tilted upright
90° and the patient is seated on a specially developed
radiolucent defecography chair. After the test the patient is
instructed to drink sufficiently to eliminate the contrast.
▪ Diary: the diary gives insight into the defecation pattern,
involuntary incontinence episodes, pad use, presence of
urge feelings, presence of urinary incontinence, alteration
in daily activities, ability to infer defecation and medica-
tion use of a patient. The diary monitors three weeks.
Since FI often goes together with urinary incontinence,
additional questions will be included concerning the
severity of urinary incontinence. Since limited informa-
tion is available about the quantity of absorbent material
use and the associated costs, the diary will enclose addi-
tional questions to get more insights into this domain and
estimate accompanying health care costs.
▪ Fecal incontinence quality of life scale (FIQL): the FIQL
is a disease-specific quality of life scale, comprising four
scales: lifestyle (10 items), coping/behavior (9 items),
depression/self-perception (7 items), and embarrassment
(3 items). The FIQL has shown to be reliable and valid
[32]. A separate quality of life scale is included as FI is con-
sidered to highly influence patients' daily life since uncer-
tainty exist on when incontinence episodes may occur.
▪ PREFAB-score: the PREFAB-score is a modified version of
the widely used and accepted PRAFAB-score in the urinary
incontinence field. The PRAFAB-score is a simple and
quickly obtained score which summarizes several objec-
tive and subjective components of the severity of urinary
incontinence complaints (ranging from 5–20) [33]. The
score has proven to be reliable, valid and responsive [34].
Since most of the PRAFAB-score, except for the "amount"
item, is applicable to fecally incontinent patients as well,
it is suggested to adapt the PRAFAB-score to fecally incon-
tinent patients. From the patients' point of view, two
aspects about excretion of feces are reported to be highly
embarrassing and affecting social life and body image:
whether the excretion can be held up by a pad or not and
whether excretion can be smelled by the environment or
not. These two aspects, reflecting social limitations, are
therefore integrated in the modified PRAFAB-score (min-
max = 6–20; range = 15).BMC Public Health 2007, 7:355 http://www.biomedcentral.com/1471-2458/7/355
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▪ Global perceived effect (GPE) (Table 2): this subjective
score reflects the change in complaints after physiother-
apy treatment compared to the period before treatment
and ranges from 1–9 points. A score of 8 or 9 indicates
much worsening of complaints and is an indication to
consider co-interventions.
Follow-up measurements are scheduled at 3, 6 and 12
months after inclusion. Primary outcome measure is the
Vaizey score [28]. Success after physiotherapy is defined as
a reduction in Vaizey score of more than four points
(16.7%) compared to baseline measurement. Recently, it
is reported that patients who rated their situation to be
better, improved four points on the Vaizey score [31]. Sec-
ondary outcome measures are anorectal resting and
squeeze pressure, rectal capacity, anorectal sensation,
diary results, FIQL, PREFAB-score and GPE-score.
Sample size
The sample size is calculated based on data from a
recently published cohort study on pelvic floor rehabilita-
tion in fecally incontinent patients [31]. Patients who
reported their situation to be better after pelvic floor reha-
bilitation showed a mean improvement score of 4.33
points on the Vaizey score and patients who rated their sit-
uation to be equal or (much) worse showed a mean
improvement score of one point (baseline average Vaizey
score is 18). As subjective improvement can not be pro-
jected as decimals on the Vaizey score, we calculated two
sample sizes: (1) with exact scores and (2) with absolute
scores to correspond with the Vaizey score and estimate of
the minimally important change (MIC). The absolute dif-
ference in improvement of four points between the
patients who rated themselves to be better and the
patients who rated themselves to be equal or (much)
worse is considered the MIC on the Vaizey score between
both trial arms [31].
The first sample size is calculated using an average Vaizey
score of 13.67 and a standard deviation of 8.45 for sample
1 and an average Vaizey score of 17 and a standard devia-
tion of 3.90 for sample 2, which resulted in a sample size
of 106 patients. The second sample size is calculated using
an average Vaizey score of 13 and a standard deviation of
8.45 for sample 1 and an average Vaizey score of 17 and a
standard deviation of 3.90 for sample 2, which resulted in
a sample size of 73 patients. The sample size is in a range
of 73 to 106 patients and we decided to include at least
106 patients to feel confident about the required sample
size.
All calculations assume a one-sided effect (first trial arm
has a better outcome than second trial arm), an alpha of
0.05, a power of 80% and an expected drop-out of 10%.
It is expected that the drop-out will be minimal since
patients will be greatly motivated to participate and
adhere to the protocol, by experiencing such an embar-
rassing and socially restricting disorder.
Referral
After diagnosis and inclusion, patients are referred to an
extramural private practice, preferably nearby their home
address. Private practices are selected with physiothera-
pists experienced in women's health, who are registered at
the Dutch Society for Physical Therapy in Pelvic Floor Dis-
orders and Pre- and Postnatal Healthcare (NVFB). They
are all educated and trained in the performance of inva-
sive techniques, as is used during digital testing and RBT.
In total, 90 physiotherapists participate throughout the
Netherlands. The initial physiotherapy session should be
within three weeks after referral. The patient hands over
an acknowledged doctor's referral letter and fifteen rectal
balloons (group 1) to the physiotherapist before the ini-
tial session. FI is not recognized as a chronic disorder and
insurance coverage is patient dependent. However, physi-
otherapy in this trial is considered as being part of usual
care, as included patients would also be excellent candi-
dates for physiotherapy outside the scope of this trial.
Since January 2006 a referral letter is not obligatory any-
more.
Physiotherapy intervention
Treatment is administered according to a standardized
protocol, which has been developed by clinicians and
physiotherapists specialized in the field of pelvic floor dis-
orders. Physiotherapy consists of pelvic floor muscle
training (PFMT) and rectal balloon training (RBT; only
trial arm one). Patients receive 12 sessions within three
months after the initial session, starting with two sessions
a week during three weeks, and thereafter reducing to one
session a week. The first session takes 45 minutes and all
subsequent sessions 35 minutes. A case report form phys-
iotherapy (CRF) is filled out for each physiotherapy ses-
sion.
Table 2: Global perceived effect (GPE-score)
To which degree have your complaints changed compared to the 
period before physiotherapy treatment?
At the moment, the complaints are .....
1. Very much improved
2. Much improved
3. Moderately improved
4. Slightly improved
5. Unchanged
6. Slightly worse
7. Moderately worse
8. Much worse
9. Very much worse
..... compared to the period before physiotherapy treatmentBMC Public Health 2007, 7:355 http://www.biomedcentral.com/1471-2458/7/355
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Physiotherapists are aware of details about the medical
history, physical examination and diary, but blinded for
findings of anal manometry, rectal capacity measurement,
anorectal sensation, anal endosonography, defecography,
FIQL and PREFAB-score. During physiotherapy sessions,
information is obtained by performing peri-anal inspec-
tion, digital rectal evaluation and rectal balloon training
(trial arm 1).
Pelvic floor muscle training
PFMT is offered to all included patients and consists of
selective voluntary contractions and relaxations of the pel-
vic floor muscles and the anal sphincter. Awareness of
these muscles is necessary, as is the avoidance of the use
of surrounding muscles like the adductors or abdominals.
PFMT aims at maximizing strength, improving duration
of strength, and improving timing and coordination of
contractions. One treatment cycle starts with a series of 8–
12 single maximum contractions, sustained for 1–3 sec-
onds. During treatment the series are extended from 1–3,
and the sustained maximum contraction from 1–3 sec-
onds to 6–8 seconds. A one-minute rest is allowed
between the cycles. One cycle is repeated three times. Fur-
thermore, patients perform three sustained submaximal
contractions of 30 seconds, with one-minute rest in
between. Patients are also instructed to perform home
exercises daily. At home the cycles and sustained contrac-
tions are done in the same way and three times daily. The
exercises are practiced in different starting positions and
circumstances, simulating as much as possible daily life.
Patients' compliance is encouraged because the home
exercises determine to a great extent the success of physi-
otherapy. Digital rectal examination is used to measure
the ability of pelvic floor muscles to contract and to quan-
tify the strength. A contraction is considered to be suffi-
cient if the pelvic floor and anal sphincter lift inward.
Rectal balloon training
A rectal balloon attached to a syringe is introduced in the
rectum and slowly inflated with air to imitate rectal con-
tents. Sensory threshold, urge sensation, and maximal tol-
erated volume are assessed. Patients with an insensitive
rectum are trained to discriminate and respond to smaller
rectal volumes of distension until a normal level of sen-
sory threshold is reached or further improvement cannot
be expected. In this way, patients receive an earlier warn-
ing from stool entering the rectum and impending defeca-
tion. In addition, patients can counteract reflex inhibition
of the internal sphincter due to awareness of stool in the
rectum [15]. Patients with a hypersensitive rectum are
trained to tolerate larger volumes by the use of progressive
distension and urge resistance until a normal level of urge
sensation is reached or the urge does not diminish with
time or is uncomfortable. Patients with weakness of the
pelvic floor muscles learn to contract these muscles imme-
diately and strongly in response to rectal filling.
Details of each session
Details of each physiotherapy session are presented in
Additional file 1: Details of each physiotherapy session.
Co-interventions
After three months follow-up the physician evaluates the
Vaizey score and the GPE-score. In case of an improve-
ment of less than four points on the Vaizey score and/or a
GPE-score of eight or nine, the clinician decides upon fur-
ther therapeutic steps. If necessary, co-interventions are
allowed after three months follow-up, although this
should be avoided as much as possible. Examples of co-
interventions are sacral nerve stimulation, anal repair or
lavage. During physiotherapy treatment, patients are not
allowed to use anal tampons.
The most common used drugs in patients with moderate
to severe FI are Loperamid and sometimes Norit. Medical
interventions and/or diet changes are first tried in the con-
servative management of patients with FI. If patients do
not benefit from medical interventions, usual care implies
referral for physiotherapy interventions. So, the majority
of patients do not use drugs before physiotherapy man-
agement since they appeared not to be helpful. Neverthe-
less, patients who use drugs before starting with
physiotherapy interventions are instructed to follow an
unchanged stable medical regimen. Therefore, ongoing
and change in medication use are monitored during the
trial. In the analysis we will account for co-interventions,
such as medication use.
Data analysis
In case of longitudinal missing data, imputation is per-
formed with the last observation carried forward method.
Main outcome is tested according to the intention to treat
principle. Both treatment groups are checked for compa-
rability regarding baseline data. An independent t-test is
done for continuous variables and a Chi-square test for
categorical variables. Analyses are performed to compare
differences within groups between baseline and short-
term follow-up (3 months) and long term follow-up (6
and 12 months) regarding primary and secondary out-
come measures. A subgroup analysis is done for the
patients with and without co-interventions. Analysis of
variance is used to determine the difference in mean
change of outcome measure between clinical subgroups.
A two-tailed p-value of 0.05 is considered to indicate sta-
tistical significance. Data analysis is done using SPSS ver-
sion 13.0 (SPSS, Inc., Chicago, Illinois). Confounders that
are taken into account are presence of urinary inconti-
nence, use of anal tampons, compliance and medication
use.BMC Public Health 2007, 7:355 http://www.biomedcentral.com/1471-2458/7/355
Page 8 of 10
(page number not for citation purposes)
Compliance
The ability of the patient to perform exercises at home is
documented at the beginning of all physiotherapy ses-
sions and if not, the reason is asked.
Discussion
Why publish a study protocol
It is decided to publish the study protocol before obtain-
ing results as we think it is important to share our
thoughts and decisions about designing this study with
other researchers in the field. Furthermore, a research arti-
cle offers only a limited space to explain and reflect on the
methods of a trial. Finally, researchers in the field are
aware of which study is ongoing, which prevents wasteful
duplication of research effort.
Bias and confounding
To minimize information bias, the performance of physi-
otherapists experienced in women's health is standard-
ized. First, only physiotherapists registered at the NVFB
are able to participate in this study. Registration approval
indicates satisfying the outlined quality criteria by the
NVFB. Second, participating physiotherapists receive a
general and physiotherapy protocol of the PhysioFIT-
study composed by experts in the field. Third, participat-
ing physiotherapists attend a general meeting. An individ-
ual visit is organised when a patient is referred to a non-
attending physiotherapist. During the meeting, the physi-
otherapists were instructed on the general and physiother-
apy protocol, a DVD-film illustrated the intended rectal
balloon training and questions and discussions were
raised. Some small adaptations were made in the protocol
based on remarks from the physiotherapists.
To further minimize information bias, adaptations were
made to the rectal balloons of the supplier. The current
balloon reached the sigmoid colon, as soon as the balloon
was filled with approximately 180 ml, possibly resulting
in colic pains. This prevented the measurement of a higher
maximal tolerated volume, although 180 ml is rarely
reached. As this balloon was inadequate for this trial,
adapted rectal therapy balloons were developed in coop-
eration with the supplier.
In this trial, it is impossible to blind on all levels. Most
importantly, the measurement of the primary outcome is
blinded as well as the outcome assessors. Blinded double
data-entry is performed to assure correct data-entry.
Confounders that are taken into account are presence of
urinary incontinence, use of anal tampons, patients' com-
pliance and medication use. The presence of urinary
incontinence can influence the perception of patients'
quality of life and estimation of severity of FI, thereby dis-
torting the scores on the FIQL, PREFAB and GPE-scores.
Furthermore, patients' compliance to the home exercise
program determines therapy intensity and indirectly ther-
apy success. Therefore, the physiotherapist asks each ses-
sion patients' compliance to the home exercise program as
formulated. The patient gives an explanation in case of
insufficient compliance. Finally, the use of anal tampons
and medication use can influence the number of involun-
tary events and stool consistency, as measured during the
visits to the physician and in the diary.
Trial arms and patient selection
The effectiveness of rectal balloon training is assessed in a
randomized controlled trial using two trial arms. A third
trial arm with RBT as a single treatment option is not
included, for the following reasons:
RBT, as a solitary therapy option, has another suggested
goal than PFMT. PFMT is hypothesized to improve
strength, coordination and endurance. RBT is hypothe-
sized to teach patients with an insensitive rectum to dis-
criminate and respond to smaller rectal volumes of
distension until a normal level of sensory threshold is
reached. Patients with a hypersensitive rectum are taught
to tolerate larger volumes by the use of progressive disten-
sion and urge resistance until a normal level of urge sen-
sation is reached. In our first trial arm RBT is performed to
strengthen the effect of PFMT. To compare this trial arm
with only PFMT, the additional effect of RBT can be
assessed.
In addition, a review by Siv Mørkved, based on seven ran-
domized controlled trials published between 1999 and
2005 on conservative treatment (PFMT with or without
biofeedback and electrical stimulation) concluded that
PFMT with and without biofeedback seems to be effective
in reducing FI [35]. This shows us that many physiother-
apy intervention trials are designed with PFMT being at
least part of the intervention. Adding a trial arm enables
us to assess the effect of a more optimized physiotherapy
intervention. Based on this and consensus in patients with
moderate to severe FI, it is decided that PFMT alone
should be at least the minimum standard of care in this
disabled patient group.
Finally, as a result of strict in- and exclusion criteria we
expect to include only one patient a week, resulting in an
unacceptable long inclusion and follow-up period or
insufficient power when extending to three trial arms.
Secondary goals
Secondary goals of the PhysioFIT-study are to assess the
psychometric properties of the PREFAB-score in clinical
practice. In addition, baseline measurements are checked
for their ability to predict outcome of physiotherapy.BMC Public Health 2007, 7:355 http://www.biomedcentral.com/1471-2458/7/355
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Furthermore, the responsiveness of the Vaizey score is
reviewed. The Vaizey score is a more common used sever-
ity score in surgical trials. But less is known about the
responsiveness of the Vaizey score in physiotherapy trials.
One study with comparable in- and exclusion criteria and
study population made a first attempt to correlate the
Vaizey score with a Global perceived effect score (31).
Patients with a decrease of 9 points rated their situation
"much better" than before physiotherapy treatment,
patients with a decrease of 4 points rated their situation
"better" and the group that rated their situation "(much)
worse or equal" had a decrease in 1 point (patients were
asked in a standardized interview to score their current sit-
uation on a scale of 1 (much worse), 2 (worse), 3 (no
change), 4 (better), or 5 (much better)). We decided that
rating the patients' situation as "better" is a minimally
important change (MIC), expressed in an absolute
number and not in a certain percentage.
Next to the Vaizey score we included the subjective GPE
score (range 1–9) in our trial as an additional outcome
measure, as we believe it is important to further investi-
gate the responsiveness of the Vaizey score in patients
with FI in physiotherapy trials.
Finally, it is expected that the outcome after physiother-
apy interventions is dependent on the baseline Vaizey
score; therefore we will perform a stratified analysis on
baseline severity scores and change scores.
Transfer of knowledge and implementation
The results of this trial will be used for recommendations
in the guideline of physiotherapy in fecally incontinent
patients. This guideline will be developed according to
method of clinical practice guideline development of the
Royal Dutch Society for Physical Therapy (KNGF) [36].
Spin off
Often, a trial is designed with the objective to make a dif-
ference in clinical daily practice. This section elaborates
on what we believe might influence clinical practice.
Based on the results of this trial, baseline measurements
are checked for their ability to be a prognostic factor for a
good or poor outcome after physiotherapy. In this way,
patients can be selected who benefit most of the proposed
physiotherapy intervention. Furthermore, this trial can
give information on the number of physiotherapy ses-
sions after which more sessions are of no further benefit.
Continuation or ending of therapy will have the same out-
come at that point. Finally, if the effectiveness of a certain
physiotherapy intervention is established, physicians can
make a well-founded decision for referral to physiother-
apy treatment, in stead of proceeding with surgical treat-
ment. In conclusion, this trial might add to clearer referral
patterns and better cooperation between physicians and
physiotherapists.
In case of insufficient result of physiotherapy and pro-
ceeding to surgical treatment, the received physiotherapy
intervention can still be of value. Patients already learned
to be aware of their pelvic floor muscles and know how to
contract them in an environment without post-surgical
stress. Besides, their pelvic floor is probably in a better
condition. Future research in this area can focus on the
effect of different pre-operative physiotherapy interven-
tions on the success of surgery in FI.
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